XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenue:      
Total revenue $ 479,948,633 $ 247,646,316 $ 219,294,306
Operating costs and expenses:      
Payroll 117,527,022 108,377,938 111,785,110
Contract services 100,757,191 42,349,982 35,913,441
Medical supplies 15,285,481 14,151,140 12,118,893
Depreciation and amortization 18,971,972 17,591,572 13,131,374
Other 31,145,690 30,401,513 30,923,750
Total operating costs and expenses 283,687,356 212,872,145 203,872,568
Gross profit 196,261,277 34,774,171 15,421,738
Corporate and other costs:      
Facilities closing costs 0 217,266 0
Acquisition costs 0 43,464 3,885,666
Stock-based compensation 16,554,898 2,835,971 189,581
Impairment of assets 3,887,216 29,082,203 0
Impairment of goodwill 3,197,391 1,139,297 398,135,038
General and administrative expenses 41,923,972 33,229,718 19,810,607
Total corporate and other costs 65,563,477 66,547,919 422,020,892
Operating income (loss) 130,697,800 (31,773,748) (406,599,154)
Interest expense, net 19,932,015 16,317,869 12,490,260
Loss on warrant liability 1,608,973 0 0
Other (income) expense (668,930) 399,182 559,299
Income (loss) before taxes 109,825,742 (48,490,799) (419,648,713)
Income tax (benefit) expense 15,020,258 (5,067,084) 13,090,905
Net income (loss) 94,805,484 (43,423,715) (432,739,618)
Less: net income (loss) attributable to noncontrolling interests 42,709,444 2,362,899 (7,959,172)
Net income (loss) attributable to Nutex Health Inc. $ 52,096,040 $ (45,786,614) $ (424,780,446)
Earnings Per Share [Abstract]      
Basic earnings (loss) per share (in dollars per share) $ 10.23 $ (10.39) $ (100.36)
Diluted (in dollars per share) $ 9.69 $ (10.39) $ (100.36)
Hospital division      
Revenue:      
Total revenue $ 449,063,683 $ 218,070,397 $ 198,508,245
Population health management division      
Revenue:      
Total revenue $ 30,884,950 $ 29,575,919 $ 20,786,061